Tracing of Patients Lost to Follow-up and HIV Transmission: Mathematical Modeling Study Based on 2 Large ART Programs in Malawi

被引:20
作者
Estill, Janne [1 ]
Tweya, Hannock [1 ,2 ,3 ]
Egger, Matthias [1 ,4 ]
Wandeler, Gilles [1 ,5 ,6 ]
Feldacker, Caryl [3 ,7 ]
Johnson, Leigh F. [4 ]
Blaser, Nello [1 ]
Vizcaya, Luisa Salazar [1 ]
Phiri, Sam [3 ]
Keiser, Olivia [1 ]
机构
[1] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland
[2] Int Union TB & Lung Dis, Paris, France
[3] Lighthouse Trust, Lilongwe, Malawi
[4] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa
[5] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland
[6] Univ Dakar, Dept Infect Dis, Dakar, Senegal
[7] Univ Washington, Int Training & Educ Ctr Hlth, Seattle, WA 98195 USA
基金
美国国家卫生研究院; 瑞士国家科学基金会; 比尔及梅琳达.盖茨基金会;
关键词
antiretroviral therapy; transmission; lost to follow-up; mathematical model; ANTIRETROVIRAL THERAPY; VIRAL LOAD; CARE; PREVENTION; LILONGWE; OUTCOMES;
D O I
10.1097/QAI.0000000000000075
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: Treatment as prevention depends on retaining HIV-infected patients in care. We investigated the effect on HIV transmission of bringing patients lost to follow-up (LTFU) back into care. Design: Mathematical model. Methods: Stochastic mathematical model of cohorts of 1000 HIV-infected patients on antiretroviral therapy, based on the data from 2 clinics in Lilongwe, Malawi. We calculated cohort viral load (sum of individual mean viral loads each year) and used a mathematical relationship between viral load and transmission probability to estimate the number of new HIV infections. We simulated 4 scenarios: "no LTFU" (all patients stay in care), "no tracing" (patients LTFU are not traced), "immediate tracing" (after missed clinic appointment), and "delayed tracing" (after 6 months). Results: About 440 of 1000 patients were LTFU over 5 years. Cohort viral loads (million copies/mL per 1000 patients) were 3.7 95% prediction interval (PrI), 2.9-4.9] for no LTFU, 8.6 (95% PrI, 7.3-10.0) for no tracing, 7.7 (95% PrI, 6.2-9.1) for immediate, and 8.0 (95% PrI, 6.7-9.5) for delayed tracing. Comparing no LTFU with no tracing, the number of new infections increased from 33 (95% PrI, 29-38) to 54 (95% PrI, 47-60) per 1000 patients. Immediate tracing prevented 3.6 (95% PrI, -3.3 to 12.8) and delayed tracing 2.5 (95% PrI, -5.8 to 11.1) new infections per 1000. Immediate tracing was more efficient than delayed tracing: to 116 and 142 tracing efforts, respectively, were needed prevent 1 new infection. Conclusions: Tracing of patients LTFU enhances the preventive effect of antiretroviral therapy, but the number of transmissions prevented is small.
引用
收藏
页码:E179 / E186
页数:8
相关论文
共 27 条
  • [1] [Anonymous], GEMS GEN MULTISTATE
  • [2] [Anonymous], INT HIV PROGR REP OC
  • [3] [Anonymous], ANT THER HIV INF AD
  • [4] [Anonymous], GLOB AIDS RESP PROGR
  • [5] [Anonymous], GLOB REP UNAIDS REP
  • [6] Peripheral neuropathy in HIV-positive patients at an antiretroviral clinic in Lilongwe, Malawi
    Beadles, W. I.
    Jahn, A.
    Weigel, R.
    Clutterbuck, D.
    [J]. TROPICAL DOCTOR, 2009, 39 (02) : 78 - 80
  • [7] Mortality of HIV-Infected Patients Starting Antiretroviral Therapy in Sub-Saharan Africa: Comparison with HIV-Unrelated Mortality
    Brinkhof, Martin W. G.
    Boulle, Andrew
    Weigel, Ralf
    Messou, Eugene
    Mathers, Colin
    Orrell, Catherine
    Dabis, Francois
    Pascoe, Margaret
    Egger, Matthias
    [J]. PLOS MEDICINE, 2009, 6 (04)
  • [8] Prevention of HIV-1 Infection with Early Antiretroviral Therapy
    Cohen, Myron S.
    Chen, Ying Q.
    McCauley, Marybeth
    Gamble, Theresa
    Hosseinipour, Mina C.
    Kumarasamy, Nagalingeswaran
    Hakim, James G.
    Kumwenda, Johnstone
    Grinsztejn, Beatriz
    Pilotto, Jose H. S.
    Godbole, Sheela V.
    Mehendale, Sanjay
    Chariyalertsak, Suwat
    Santos, Breno R.
    Mayer, Kenneth H.
    Hoffman, Irving F.
    Eshleman, Susan H.
    Piwowar-Manning, Estelle
    Wang, Lei
    Makhema, Joseph
    Mills, Lisa A.
    de Bruyn, Guy
    Sanne, Ian
    Eron, Joseph
    Gallant, Joel
    Havlir, Diane
    Swindells, Susan
    Ribaudo, Heather
    Elharrar, Vanessa
    Burns, David
    Taha, Taha E.
    Nielsen-Saines, Karin
    Celentano, David
    Essex, Max
    Fleming, Thomas R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (06) : 493 - 505
  • [9] Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco
    Das, Moupali
    Chu, Priscilla Lee
    Santos, Glenn-Milo
    Scheer, Susan
    Vittinghoff, Eric
    McFarland, Willi
    Colfax, Grant N.
    [J]. PLOS ONE, 2010, 5 (06):
  • [10] Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study
    Estill, Janne
    Egger, Matthias
    Blaser, Nello
    Vizcaya, Luisa Salazar
    Garone, Daniela
    Wood, Robin
    Campbell, Jennifer
    Hallett, Timothy B.
    Keiser, Olivia
    [J]. AIDS, 2013, 27 (09) : 1483 - 1492